It analyzes pathway-level variants (GLP1R (rs6923761), GIPR, FTO (rs9939609), and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
Mitigate risks of therapy discontinuation
The following recommendations support optimal outcomes: Prescribing decisions should be individualised, weighing the substantial benefits of improved glycaemic control and weight reduction against any theoretical skeletal concerns
SeekPeptides has analyzed the clinical data, community reports, and mechanistic research to create the most comprehensive resource available on this topic
RELATED: What causes acid reflux at night
Schedule your session now and experience the refreshing benefits of our tailored IV vitamin therapy